Quantcast

Latest Patent law Stories

2014-05-08 20:23:36

DUBLIN, May 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ccwnhk/us_patent) has announced the addition of the "US Patent Practice - What European Patent Attorneys Need to Know (Seminar, London)" [http://www.researchandmarkets.com/research/ccwnhk/us_patent ] conference to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The US Patent Practice - What European Patent Attorneys Need to Know seminar...

2014-05-08 08:43:02

Optimize Content Purchasing and Windowing using New Tool that Unifies Data Across Linear, On Demand, and Hundreds of Digital Platforms NEW YORK, May 8, 2014 /PRNewswire/ -- Content owners were in trouble. With the number of outlets and windows available for content growing exponentially, they struggled to get valid actionable information about usage, revenues, and royalties for their content. Each distribution partner has different, proprietary formats, measures, and schedules for reporting...

2014-05-07 20:24:29

LONDON, May 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Cancer Diagnostics Partnering Terms and Agreementshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/cancer_diagnostics_partnering_terms_agreements.htmlThe Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in cancer diagnostics...

2014-05-06 08:42:51

Jim Reddoch, PhD, Royalty Pharma Executive Vice President for Research and Investments Joins Avillion Board LONDON and NEW YORK, May 6, 2014 /PRNewswire/ -- Avillion LLP, a company focused on co-development and financing of late-stage pharmaceutical candidates from Phase 3 clinical development through marketing approval, announced that Royalty Pharma has become an investor, joining Abingworth LLP and Clarus Ventures. Royalty Pharma will be represented on the Avillion Board by Jim...

2014-05-06 08:31:15

Digital marketing patents strengthen RevTrax's proprietary POS validation solutions NEW YORK, May 6, 2014 /PRNewswire/ -- Today, RevTrax announced the acquisition of a patent portfolio including three U.S. patents, three U.S. applications and three foreign applications. The patents disclose a system for secure online distribution and validation of promotions across multiple technologies, including print-at-home, load-to-card, mobile and e-commerce....

2014-04-30 16:24:04

RED BANK, N.J., April 30, 2014 /PRNewswire/ -- The Trustees of North European Oil Royalty Trust (NYSE: NRT) today announced a quarterly distribution of $0.56 per unit for the second quarter of fiscal 2014, payable on May 28, 2014 to holders of record on May 15, 2014. Natural gas sold during the first calendar quarter of 2014 is the primary source of royalty income on which the May 2014 distribution is based. John R. Van Kirk, Managing Director, reported that this year's quarterly...

2014-04-30 12:35:58

HSINCHU, April 30, 2014 /PRNewswire/ -- Macronix International Co., Ltd. (TSE: 2337), a global leader providing non-volatile memory solutions, announced that it will continue to take vigorous actions against the patent litigations filed by Spansion, Inc. in the U.S. International Trade Commission ("ITC") and the U.S. District Court in the Northern District of California in late April of 2014. Macronix will defend its products and assist its customers in defending such claim of...

2014-04-29 04:21:58

LONDON and MUNICH, April 29, 2014 /PRNewswire/ -- - Toumazou developed game-changing rapid "do-it-yourself" DNA test - Microchip instead of genetics lab: analysis via USB stick saves time and money - British scientist is pioneer of personalised medical diagnostics - 50 patents secure prolific inventor Toumazou place in growth market worth billions - EPO President Benoît Battistelli: "Toumazou's work creates immense...

2014-04-25 08:31:25

Lobbying war-driven scrutiny of patent system set to continue OTTAWA, Ontario, April 25, 2014 /PRNewswire/ -- For World IP Day 2014, TechInsights, the leading provider of intellectual property consulting, patent brokerage and technical analysis services, takes a look at the significant issues impacting technology patent owners. Intellectual property (IP) and patents continued to experience increased shareholder, media and public awareness throughout 2013, and this will be ongoing...

2014-04-21 12:29:58

FALLS CHURCH, Va., April 21, 2014 /PRNewswire-USNewswire/ -- Acentia, a premier provider of technology and management solutions, today announced it was awarded a 1-year, $2.5-million contract by the U.S. Patent and Trademark Office (USPTO). The company will provide software design and development services to develop and implement Phase 2 of the Agency's Cooperative Patent Classification (CPC) Database project. The CPC effort is a joint partnership between the USPTO and the European...


Latest Patent law Reference Libraries

OncoMouse
2013-10-02 09:29:43

The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...

More Articles (1 articles) »
Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related